BIOMAT Database Logo BIOMAT Database Logo

Kanamycin in pulmonary tuberculosis. 1958

M SHAPIRO, and L HYDE

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

M SHAPIRO, and L HYDE
Kanamycin in pulmonary tuberculosis.
January 1958, Antibiotics annual,
M SHAPIRO, and L HYDE
[Experience with kanamycin in pulmonary tuberculosis].
October 1961, El Dia medico,
M SHAPIRO, and L HYDE
[Management of pulmonary tuberculosis by kanamycin].
December 1967, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
M SHAPIRO, and L HYDE
[Surgery of pulmonary tuberculosis and kanamycin].
December 1967, Nihon Ishikai zasshi. Journal of the Japan Medical Association,
M SHAPIRO, and L HYDE
Kanamycin. I. Treatment of pulmonary tuberculosis.
July 1960, The American review of respiratory disease,
M SHAPIRO, and L HYDE
[Kanamycin in the treatment of pulmonary tuberculosis].
September 1961, Revista clinica espanola,
M SHAPIRO, and L HYDE
Kanamycin: its therapeutic record in pulmonary tuberculosis.
June 1966, Annals of the New York Academy of Sciences,
M SHAPIRO, and L HYDE
[Kanamycin, aerosols and pulmonary tuberculosis. Treatment of pulmonary tuberculosis with aerosols of kanamycin combined with diffusion factors].
January 1961, Vie medicale (Paris, France : 1920),
M SHAPIRO, and L HYDE
Clinical experience with kanamycin in chronic pulmonary tuberculosis.
September 1958, Annals of the New York Academy of Sciences,
M SHAPIRO, and L HYDE
The treatment of pulmonary tuberculosis with kanamycin.
January 1963, Chemotherapia,
Copied contents to your clipboard!